Protagonist Therapeutics logo
Protagonist Therapeutics PTGX
$ 40.88 3.39%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Protagonist Therapeutics Operating Income 2011-2024 | PTGX

Annual Operating Income Protagonist Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-93.7 M -131 M -126 M -64.5 M -80.5 M -42.3 M -37.9 M -32.7 M -14.8 M -9.32 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-9.32 M -131 M -63.3 M

Quarterly Operating Income Protagonist Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-41.5 M -38.8 M 206 M - -38.3 M -42.4 M -36 M - -32.3 M -41.4 M -21.1 M - -33.9 M -30.9 M -24 M - -7.77 M -18.2 M -19.7 M -17.3 M -17.2 M -31.4 M -14.6 M -15.4 M -9.39 M -9.24 M -8.23 M -3.51 M -4.98 M -15.1 M -14.3 M -11.4 M -7.14 M -7.09 M -7.04 M -5 M -4.02 M -3.08 M -2.69 M - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
206 M -42.4 M -12.2 M